| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 431.444 | 90 |
| GSM780708 | Untreated after 4 days (C2_1) | 439.434 | 91 |
| GSM780709 | Untreated after 4 days (C3_1) | 513.561 | 92 |
| GSM780719 | Untreated after 4 days (C1_2) | 457.735 | 91 |
| GSM780720 | Untreated after 4 days (C2_2) | 533.802 | 92 |
| GSM780721 | Untreated after 4 days (C3_2) | 522.575 | 92 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 449.079 | 91 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 432.864 | 90 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 323.925 | 88 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 413.306 | 90 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 414.993 | 90 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 371.884 | 89 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 384.89 | 90 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 373.497 | 89 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 437.747 | 91 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 453.942 | 91 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 423.388 | 90 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 453.422 | 91 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 436.055 | 91 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 431.276 | 90 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 371.748 | 89 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 440.04 | 91 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 466.735 | 91 |